A Study of IBI3031 in Participants With Thyroid Eye Disease

Clinical trial NCT07622368 · RECRUITING

Trial details

NCT number: NCT07622368
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Thyroid Eye Disease

Start date: 2026-06-30
Primary completion: 2027-06-15
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.